Endocrine testing is a diagnostic test used to determine endocrine hormone concentration. It is basically used to diagnose hormone-related disorders. Endocrine glands secrete hormones directly into the bloodstream thereby helping in the regulation of various body functions such as growth and development, metabolism, reproduction, stimuli response, and homeostasis. Various endocrine glands present in the body include pituitary glands, thyroid glands, hypothalamus, pancreas, and adrenal glands. Any imbalance in the hormones secreted by these glands leads to a certain disorder, therefore, they are important markers to diagnose a certain condition. Insulin, thyroid-stimulating hormone, follicle-stimulating hormones, human chorionic gonadotropin, progesterone, testosterone, cortisol, and prolactin are some of the endocrine tests.
The global endocrine testing market was valued at US$ 2.95 billion in 2017 and is expected to witness a CAGR of 4.9% over the forecast period (2019 – 2026).
Growing prevalence of endocrine disorders is projected to drive the growth of the endocrine testing market
Increasing prevalence of endocrinal disorders such as diabetes, hypo/hyperthyroidism, infertility, multiple endocrine neoplasia 1 and 2, hypo/hyperadrenocorticism and hypogonadism are expected to fuel the growth of the endocrine testing market. hypothyroidism and hyperthyroidism are the common fastest-growing endocrinal disorder. According to the American Thyroid Association, in 2017, around 20 million U.S. citizens experience thyroid annually. An estimated 12% of the U.S. population is expected to suffer from thyroid disease in their lifetime. Moreover, around 60% of people who have thyroid are unaware of their disease. It is a common endocrine disorder in emerging economies due to iodine deficiency in the diet. According to a study published in the Indian Journal of Endocrinology and Metabolism (IJEM), thyroid disease in India has an incidence of 11% (4-5% for developed countries) and as per an epidemiological study published in IJEM in 2011, around 42 million people were affected by the thyroid disorder. Imbalance in sex hormones such as follicle-stimulating hormone leads to various disease including infertility conditions. According to a report by the Maternal Health Task Force, in 2017, around 50 million couples experience infertility globally each year. Other endocrinal diseases such as Cushing syndrome and gigantism would also see steady prevalence which would present the growth opportunity in the endocrine testing market.
Download free PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1755
Increasing new products launched by the key players in test kits are projected to propel the growth of the endocrine testing market
Companies are launching innovative products to cater to the end-user need and increase the market footprint in the endocrine testing market. In 2017, Beckman Coulter Diagnostics received FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use. AMH test helps healthcare providers in the assessment of a woman’s ovarian reserve, thereby aid in the clinical management of women facing infertility or women planning to become pregnant later in life. The Access AMH assay is a paramagnetic particle chemiluminescent immunoassay for the quantitative determination of AMH levels. The test can be used in conjunction with other clinical and laboratory findings such as antral follicle count, before starting fertility therapy. Companies are also undergoing strategic collaboration to increase market share. For instance, in 2017, Quest diagnostics and Walmart collaborated, under which Quest would open laboratory testing services at 15 Walmart locations initially to gradually increase the same.
Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, Quest Diagnostics, and others.
Browse Research Report At: https://www.coherentmarketinsights.com/market-insight/endocrine-testing-market-1755
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Name: Mr. Raj Shah
Phone: US +12067016702 / UK +4402081334027